Business
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025
WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has been honored with four prestigious awards at the Asia-Pacific Biopharma Excellence Awards 2025.
About this update from Wuxi Xdc Cayman, Inc.
[{"type":"text","content":"SHANGHAI, March 13, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has been honored with four prestigious awards at the Asia-Pacific Biopharma Excellence Awards 2025.","length":395,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":170,"url":"https://media.zenfs.com/en/prnewswire.com/b4e9ed4c1a5f396a0d7fc710fd3f680f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/WK3stk9SKJDBAB6U.LELpw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTMwMDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b4e9ed4c1a5f396a0d7fc710fd3f680f","width":400,"height":170}},"href":"https://mma.prnewswire.com/media/2640911/image_5027433_19580493.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The Asia-Pacific Biopharma Excellence Awards honor companies annually that have exhibited outstanding performance and achievement in the biopharmaceutical sector. These accolades underscore WuXi XDC's leadership, innovation, and fully integrated CRDMO platform, empowering global clients from early discovery to commercial manufacturing.","length":341,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Industry-leading development and manufacturing capabilities (Best ADC CDMO in Asia & China): WuXi XDC's state-of-the-art facilities and global dual-sourcing strategy enable seamless CMC development and GMP manufacturing, accelerating the timeline while ensuring a high success rate and regulatory excellence.","length":321,"tagName":"p"}]},{"val":[{"type":"text","content":"Innovation in Discovery & Development (Best ADC CRO in Asia): WuXi XDC's proprietary conjugation and payload-linker technologies, along with the incorporation of external technologies through partnerships, drive ADC and XDC discovery, optimization, and IND-enabling studies, expediting clients' clinical advancement.","length":328,"tagName":"p"}]},{"val":[{"type":"text","content":"Pioneering ADC Technology (Best ADC Platform Technology): Through next-generation payload-linker innovations an...